About Mitofam
Add Pedigree
Help
About Mitofam
Add Pedigree
Help
MT-TM
A4415G
A4435G
A4435G-F11
A4435G-F10
A4435G-F9
A4435G-F6
A4435G-F4
A4435G-F3
A4435G-F2
A4435G-F1
C4467A
C4467A-F1
G4403A
G4412A
G4412A-F1
G4450A
G4450A-F2
T4409C
T4414C
T4414C-F1
T4454C
T4454C-F2
Edit by Mitofam Team
-
+
首页
G4403A
# **General Information** | **Position** | **4403** | **Variant** | **m.4403G\>A** | **Locus** | **MT\-TM** | **RNA** | **tRNA Met** | | --- | --- | --- | --- | --- | --- | --- | --- | | **Homoplasmy** | \- | **Heteroplasmy** | \+ | **mitoTIP** | 84\.80% | **Pathogenicity** | Reported | "Pathogenicity" status is derived from published literature or predictions from bioinformatics tools. Researchers and clinicians are cautioned that additional data and/or analysis may still be necessary to confirm the pathological significance of these variants. For more information, please see [Mitofam Info](https://mitofam.com/doc/385/). # **Pedigree Information** The **m.4403G\>A** variant in MT\-TM has been reported in 2 pedigrees. To date, 4 carriers have been reported. Reported mutation loads ranged from 0% to 77%, with a median of 0% overall; affected carriers showed mutation loads from 0% to 77%, with a median of 31\.5%; unaffected carriers showed mutation loads from 0%, with a median of 0%. In one affected carrier, the mutation was undetectable in blood (0%) and urine (0%) but exceeded 20% in muscle (63%). The main clinical manifestations among affected carriers included and mild steppage gait, diffuse muscle atrophy and weakness, exercise intolerance, progressive muscle weakness and atrophy had a muscle biopsy characterized by a combination of dystrophic features, short stature, and unusual dystrophic features on muscle biopsy. | **No.** | **Position** | **Variant** | **Family ID** | **Nationality** | **Diseases** | **Unaffected Maternal Relatives** | **Affected Maternal Relatives** | **Publication Year** | **PMID/Ref** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 4403 | m.4403G\>A | G4403A\-F1 | Filipino | Mitochondrial Myopathy | ND | ND | 2014 | [24711008](https://pubmed.ncbi.nlm.nih.gov/24711008/) | | | 2 | 4403 | m.4403G\>A | G4403A\-F2 | ND | Mitochondrial Myopathy | ND | ND | 2014 | [24711008](https://pubmed.ncbi.nlm.nih.gov/24711008/) | | # **Carrier Information** | **No.** | **Position** | **Variant** | **Family ID** | **Carrier ID** | **Type (Fam/De novo/Uninf)** | **Gender (F/M)** | **Proband (Y/N)** | **Affected (Y/N)** | **Die/Alive(D/A)** | **Age** | **Blood Mutant Level** | **Muscle Mutant level** | **Urine Mutant level** | **Other Mutant level** | **Clinical Features** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 4403 | m.4403G\>A | G4403A\-F1 | G4403A\-F1\-P1 | De novo | F | Y | Y | A | 61 | 0 | 63% | 0 | / | progressive muscle weakness and atrophy had a muscle biopsy characterized by a combination of dystrophic features | | | 2 | 4403 | m.4403G\>A | G4403A\-F1 | G4403A\-F1\-P2 | Uninf | F | N | N | A | ND | 0 | 0 | 0 | / | Healthy | | | 3 | 4403 | m.4403G\>A | G4403A\-F1 | G4403A\-F1\-P3 | Uninf | F | N | N | A | ND | 0 | 0 | 0 | / | Healthy | | | 4 | 4403 | m.4403G\>A | G4403A\-F2 | G4403A\-F2\-P1 | De novo | F | Y | Y | A | 28 | / | 77% | / | / | unusual dystrophic features on muscle biopsy;exercise intolerance;short stature, diffuse muscle atrophy and weakness,and mild steppage gait | | For abbreviations and other usage instructions, please see [Mitofam Info](https://mitofam.com/doc/385/).
Haoying Chen
2026年6月22日 15:53
转发
收藏文档
上一篇
下一篇
手机扫码
复制链接
手机扫一扫转发分享
复制链接
分享
链接
类型
密码
更新密码
有效期
Markdown文件
Word文件
PDF文档
PDF文档(打印)